However, there are marked differences in cancer predisposition: the ANKRD26 variant predisposes to myeloid malignancies, ETV6 predominantly predisposes to B-cell ALL, and RUNX1 is associated with myeloid malignancies, and, to a lesser extent, predisposes to T-cell ALL [151]. The gene discussed is RUNX1; the disease is myeloid neoplasm.